81ssbanners2021nocta1128x191.jpeg

ADA Meeting News and Additional Diabetes Videos

81ssbanners2021nocta1128x191.jpeg

Hopefully you have noticed from either our Twitter feed or Facebook page that Dr. Peters and Mark Harmel were covering the virtual ADA meetings. Multiple Medscape videos have been posted (all shot or directed by Mark) and you have the option of watching the video or reading the transcript on Medscape after completing a free one-time registration to create an account.

 

In addition to the recent ADA news there are also many other videos that have posted since the Winter newsletter that may interest you. These earlier videos can be found after the meeting news.

Videos Previews or News Related to the 81st ADA Scientific Sessions by Dr. Peters:

CGM in Type 2 Diabetes: What I Learned From the MOBILE Study

Anne Peters discusses the benefit of CGM in patients with type 2 diabetes on basal insulin, adding that there is much to be done in educating both patients and healthcare professionals about CGM.

Medscape Diabetes & Endocrinology, Jun 30, 2021

New Guidelines for Type 1 Diabetes in Adults: An Overview

Dr Anne Peters summarizes and gives highlights from the new ADA/EASD draft guidelines for the management of type 1 diabetes in adults.

Medscape Diabetes & Endocrinology, Jun 28, 2021

All About Wegovy for Weight Loss

Anne Peters talks about the newly approved semaglutide (Wegovy) for weight loss -- the various trials, indications and warnings, dosing, and expectations.

Medscape Diabetes & Endocrinology, Jun 21, 2021

 

Peters on Tirzepatide: 'Impressive, but We Need to Know More'

Dr Anne Peters discusses tirzepatide and the topline results from the SURPASS trials. 

Medscape Diabetes & Endocrinology, Jun 18, 2021

Videos Reports from the 81st ADA Scientific Sessions by Mark Harmel, MPH:

After Metformin, Which Drug Makes the GRADE?

Which medication should be added after metformin? The GRADE study attempts to fill the evidence gap.

Perspectives, Jul 9, 2021

CGM in Hospitals as Standard of Care: What Have We Learned?

Isn't glucose yet another vital sign? Dr Athena Philis-Tsimikas argues that CGM as standard of care in the hospital allows for better management of patients with diabetes. 
Perspectives, Jul 22, 2021

New FDA Guidance on T2D Trial Design Provides Flexibility

The FDA released new draft guidance for the evaluation of type 2 diabetes drugs. Dr John Buse discusses the impact this could have on clinical trials and the medications we might see from the changes.

Perspectives, Jul 20, 2021

With Tirzepatide, a 'Great Future' for Patients With T2D

Dr Juan Frias discusses results from the SURPASS trials and how tirzepatide might eventually be used in the clinical setting.
Perspectives, Jul 15, 2021

Agents of Change: 4 Ways to Battle Social Determinants of Health

How do we help patients navigate social determinants of health? Dr Shivani Agarwal outlines four simple actions that can lead to big outcomes.Perspectives, Jun 29, 2021


The Best Way to Prevent Type 2 Diabetes? Change Our Target

Type 2 diabetes prevention strategies need to be focused on environmental changes more than individual changes in order to be effective, argues Dr Hertzel Gerstein.

Perspectives, Jul 7, 2021

Understanding COVID and Diabetes: Ominous Findings, Next Steps

What do we know about the epidemiology of diabetes and COVID? Dr Edward Gregg discusses learnings from the past year, and the steps needed to reduce morbidity and mortality in the diabetes population.

Perspectives, Jul 1, 2021


Earlier Videos of Interest to Patients by Dr. Peters:

 

 

 

 

 

 

 

 

 

 

 

 

 

Updates on Semaglutide for Weight Loss, From ENDO 2021
Dr Anne Peters discusses updates from the STEP trials that were presented at ENDO 2021.

Medscape Diabetes & Endocrinology, April 20, 2021 

 

The Omnipod 5 System: Trial Results From ENDO 2021
Find out why Dr Anne Peters was 'incredibly excited' to see data presented from the Omnipod 5 clinical trials.

Medscape Diabetes & Endocrinology, April 02, 2021 

 

SGLT2 Inhibitors in T1D: 'People Are Using Them Now' 
Dr Anne Peters talks about what you need to know regarding off-label use of SGLT2 inhibitors in type 1 diabetes.

Medscape Diabetes & Endocrinology, March 30, 2021 

 

Managing Pregnancy in T1D: 'One of the Hardest Things We Do' 
Dr Anne Peters discusses blood glucose targets and continuous glucose monitoring in pregnant patients with type 1 diabetes.

Medscape Diabetes & Endocrinology, March 11, 2021 

 

"Heart" of the New ADA Guidelines: Pharmacologic Approaches 
Dr Anne Peters continues her overview of the ADA 2021 Standards of Care, focusing on the updates to pharmacologic management of glycemia.

Medscape Diabetes & Endocrinology, January 07, 2021 

 

Key Changes to the 2021 ADA Standards of Care  
Dr Anne Peters provides an overview of important changes to the first half of the ADA 2021 Standards of Care.

Medscape Diabetes & Endocrinology, January 04, 2021

Wexler.png
medscape-anne.png
Medscape.jpeg

L A T E S T   N E W S

AnnePeters21.jpg

MESSAGE FROM THE DIRECTOR

After a difficult and unsettling years we made it to the reopening of California! Although not necessarily...

READ MORE...

bret.jpg

THE HANKEY GRANT

Over the past 20 plus years our diabetes group has made many contributions to the care and treatment of people with...

READ MORE...

disaster.jpg

PREPARING FOR NATURAL DISASTERS

There is a historic drought impacting much of the Western half of the United States and conditions are...

READ MORE...

81ssbanners2021nocta1128x191.jpeg

ADA MEETING NEWS AND
ADDITIONAL VIDEOS

Hopefully you have noticed from either our Twitter feed or our Facebook page that Dr. Peters and Mark ...

READ MORE...

iphone-calc.jpg

SUMMER RESEARCH UPDATE

On the research front, we have results to report from two completed trials, we are continuing to...

READ MORE...